Company Dynamic
-
India has decided to impose anti-dumping duties on Sodium cyanide and initiate an anti-dumping investigation on Glufosinate ammonium
2024-07-02India has decided to impose anti-dumping duties on Sodium cyanide and initiate an anti-dumping investigation on Glufosinate ammonium
-
Australia plans the registration of acaricide Interrupt 240 SC(Bayer) and its active ingredient Spiromesifen
2024-07-02The Australian Pesticide and Veterinary Medicine Authority (APVMA) has announced the proposed registration of the Bayer acaricide Interrupt 240 SC (containing 240g/L Spiromesifen SC) and its active ingredient Spiromesifen.
-
Shandong Lubachem terminated the IPO
2024-07-01On June 27, the news of the Shanghai Stock Exchange showed that the Shanghai Stock Exchange terminated its main board listing audit due to the withdrawal of Shandong Lubachem and its sponsor Minsheng Securities Co., LTD.
-
Syngenta registered two active ingredients in the United States, Isocycloseram and Cyclobutrifluram
2024-07-01Syngenta recently announced that two of its innovative active ingredients, Isocycloseram and Cyclobutrifluram, are awaiting registration with the U.S. Environmental Protection Agency (EPA) for use in the specialty solutions market.
-
AstraZeneca Submits COVID-19 Preventive Drug Sipavibart for Accelerated Review in the EU
2024-07-01AstraZeneca stated in a Monday announcement that the European Union's drug regulatory agency has formally accepted the marketing authorization application for its investigational COVID-19 preventive drug sipavibart.
-
Federal Judge Rejects Cancer Victims' Bid to Block Johnson & Johnson Bankruptcy
2024-07-01On this past Friday, Federal Judge Michael Shipp carefully evaluated a request from a group of cancer victims to block Johnson & Johnson's bankruptcy plans, and ultimately rejected their motion.
-
French Pharmaceutical Giant Sanofi to Invest €13-15 Billion in German Production Facility
2024-07-01Sanofi plans to make a major investment of between €13 billion and €15 billion (equivalent to $14 billion to $16 billion) in its large production facility located in Frankfurt, Germany, for the manufacturing of its insulin brand Lantus.
-
Ongoing Investigation into Deaths Potentially Linked to Monascus-Derived Supplements in Japan
2024-07-01On this past Friday, Japanese healthcare product manufacturer Kobayashi Pharmaceutical formally announced that it is conducting a thorough investigation into 76 reported deaths potentially associated with its tablets containing red yeast rice.
-
Evonik Opens Life Sciences R&D Center in Greater Boston
2024-07-01Creavis, Evonik’s strategic innovation unit and business incubator, has opened an Innovation Satellite with laboratories and offices in the Greater Boston metropolitan area in Cambridge, Massachusetts.
-
Evonik opens new AEROSIL silica plant
2024-07-01Evonik has opened a plant for its innovative dispersing technology for fumed silica at its site in Rheinfelden. The move strengthens the specialty chemicals company’s position as a leading supplier of high-quality silicas from the AEROSIL range.
-
Protease Is An Enzyme That Breaks Down | Detailed Explanation
2024-07-01Protease is an enzyme that breaks down proteins. What is protease and what are the types of protease? How does protease work? Get the answers you need, now!
-
-
Albaugh has launched several products for Brazilian citrus, such as Flumioxazin and Bifenthrin
2024-06-28North American-based Albaugh has launched a series of new herbicides and insecticides for citrus cultivation in the Brazilian market, aiming to further expand its product portfolio in this sector and meet specific agricultural needs.
-
Agri Tech(India) will be held in Bangalore from August 22-24
2024-06-28Agri Tech(India) will be held in Bangalore from August 22-24
-
Haier's Strategic Acquisitions and Innovations Transforming China's Blood Product Industry
2024-06-28The development history of China's blood product industry can be described as an epic saga of large-scale mergers and acquisitions.
-
Eli Lilly's Zepbound (Tizepatide) Demonstrates Promising Results in Treating Obesity and Obstructive Sleep Apnea
2024-06-28In the era of rapid advancement in medical technology, obesity and its related complications are becoming a global public health challenge.
-
Pfizer's Resurgence in the RSV Vaccine Market: Reclaiming Ground and Intensifying Global Competition
2024-06-28After temporarily losing out to GSK in the race for an RSV vaccine with Pfizer choosing not to stand still, the company has instead regrouped and is preparing to launch another assault on the market.
-
Tate & Lyle Acquires CP KELCO for $1.8 Billion to Strengthen Plant-Based Portfolio
2024-06-28Tate & Lyle, a British sweetener manufacturer, announced the acquisition of US-based CP Kelco for $1.8 billion. This strategic move is intended to boost Tate & Lyle's specialty ingredients business to meet the growing demand for plant-based products.
-
Charles River's Strategic Investments and Financial Performance
2024-06-28Charles River has implemented a series of investment strategies, including acquisitions, technology partnerships, and internal development, to gain access to innovative technologies and expertise.
-
Henkel publishes white paper on new coating technology for metal pretreatment
2024-06-28Henkel Adhesive Technologies has published a new white paper dedicated to the cleaning agent and coating technology.
Hot News
-
Muriatic Acid vs Hydrochloric Acid: What's the Difference?
-
Is pyrethrin and permethrin the same-What are the key differences
-
BASF announced that due to force majeure, this product has ceased supply!
-
HFC-134a vs R-134a: Key Differences and Applications
-
What Is The Difference Between Washing Soda And Soda Ash
-
Acetone vs Alcohol: Key Differences, Uses, and Safety Compared
-
Lysinate Glycinate vs Glycinate: Key Differences and Benefits
-
Polypropylene vs Polycarbonate: What Is the Difference?
-
What is the Difference Between NaCl and NaCl2?
-
The merger and reorganization of ChemChina and Sinochem is in progress